Recent News

• 04.24.2025 - Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET
• 04.24.2025 - Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET
• 04.11.2025 - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 04.11.2025 - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 04.11.2025 - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.11.2025 - Leerink Partners Global Healthcare Conference
• 03.11.2025 - Leerink Partners Global Healthcare Conference
• 03.04.2025 - Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
• 03.04.2025 - Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
• 03.04.2025 - Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference

Recent Filings

• 04.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.04.2025 - 8-K Current report
• 02.25.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.25.2025 - 8-K Current report
• 02.25.2025 - S-8 Securities to be offered to employees in employee benefit plans